Bristol Myers Squibb (BMY) Com Stk USD 0.10 (CDI)

Sell:$55.83Buy:$55.84$0.04 (0.07%)

Prices delayed by at least 15 minutes
Sell:$55.83
Buy:$55.84
Change:$0.04 (0.07%)
Deal now
Prices delayed by at least 15 minutes
Sell:$55.83
Buy:$55.84
Change:$0.04 (0.07%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.

Key people

Christopher S. Boerner
Chairman of the Board, Chief Executive Officer, Chief Operating Officer
David V. Elkins
Executive Vice President, Chief Financial Officer, Member of the Leadership Team
Lynelle Hoch
President, Cell Therapy Organization, Member of the Leadership Team
Amanda Poole
Chief Human Resource Officer, Executive Vice President, Member of the Leadership Team
Greg Scott Meyers
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership Team
Sandra Leung
Executive Vice President, General Counsel, Member of the Leadership Team
Cari Gallman
Executive Vice President, Corporate Affairs, Member of the Leadership Team
Samit Hirawat
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership Team
Adam Lenkowsky
Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team
Robert Plenge
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership Team
Theodore R. Samuels
Lead Independent Director
Peter J. Arduini
Independent Director
Deepak L. Bhatt
Independent Director
Julia A. Haller
Independent Director
Michael R. Mcmullen
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1101221083
  • Market cap
    $111.57bn
  • Employees
    34,100
  • Shares in issue
    2.92bn
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.